Logo Logo
Hilfe
Hilfe
Switch Language to English

Jost, Tina; Schuster, Barbara; Heinzerling, Lucie; Weissmann, Thomas; Fietkau, Rainer; Distel, Luitpold V. und Hecht, Markus (2022): Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients. In: Strahlentherapie und Onkologie, Bd. 198, Nr. 9: S. 838-848

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Purpose Kinase inhibitors (KI) are known to increase radiosensitivity, which can lead to increased risk of side effects. Data about interactions of commonly used KI with ionizing radiation on healthy tissue are rare. Patients and methods Freshly drawn blood samples were analyzed using three-color FISH (fluorescence in situ hybridization) to measure individual radiosensitivity via chromosomal aberrations after irradiation (2 Gy). Thresholds of 0.5 and 0.6 breaks/metaphase (B/M) indicate moderate or clearly increased radiosensitivity. Results The cohorts consisted of healthy individuals (NEG, n = 219), radiosensitive patients (POS, n = 24), cancer patients (n = 452) and cancer patients during KI therapy (n = 49). In healthy individuals radiosensitivity (>= 0.6 B/M) was clearly increased in 5% of all cases, while in the radiosensitive cohort 79% were elevated. KI therapy increased the rate of sensitive patients (>= 0.6 B/M) to 35% significantly compared to 19% in cancer patients without KI (p = 0.014). Increased radiosensitivity of peripheral blood mononuclear cells (PBMCs) among patients occurred in six of seven KI subgroups. The mean B/M values significantly increased during KI therapy (0.47 +/- 0.20 B/M without compared to 0.50 +/- 0.19 B/M with KI, p = 0.047). Conclusions Kinase inhibitors can intensify individual radiosensitivity of PBMCs distinctly in 85% of tested drugs.

Dokument bearbeiten Dokument bearbeiten